Imperial College London

Dr Jayant Kumar, MD, MS, Master in HBP Surgery, MRCS(Ed), FACS, PhD

Faculty of MedicineDepartment of Surgery & Cancer

Honorary Clinical Research Fellow



j.kumar Website




Commonwealth BuildingHammersmith Campus






Senior Clinical Fellow Renal and Pancreatic Transplant Surgery

Honorary Fellow (HPB Surgery)


Dr. Jayant’s work at Imperial College London is assessing the clinical and immunomodulatory aspects of Radiofrequency (RF) energy in the management of Liver and Pancreatic Cancer. He is particularly interested in the development of newer techniques of pancreatic and liver cancer management. He is involved in the understanding of immunological changes following the application of RF-based liver resection device in various liver cancers, and its implication on clinical outcomes in advanced liver cancer with checkpoint inhibitors.

His recent study on liver cancer "Assessing the impact and benefits of RF-assisted parenchymal sparing liver resection on post-hepatectomy liver failure" reflects the development of the RF-assisted liver resection using the Habib-4X as a feasible and safe technique of liver resection with a low incidence of post-hepatectomy liver failure and mortality.

In addition, he is also involved in the project "RF-assisted pancreaticoduodenectomy for locally advanced pancreatic adenocarcinoma- A novel approach" which leads to the development of newer RF-assisted pancreaticoduodenectomy technique which is more feasible and safer than a vascular resection with a conventional technique. 

Dr. Jayant has accrued several accolades for his contribution to medical sciences including Best Investigator Award from American College of Surgeons in 2015. Moreover, his research interest includes understanding the role of normothermic perfusion in liver transplantation and published papers and was recipient of the Young Investigator Award from "Asia-Pacific Primary Liver Cancer Expert Meeting, Seoul South Korea" and "Japanese Digestive Disease Week 2018" Kobe, Japan. 

Dr. Jayant holds an MD certification, a Master in Hepatobiliary and Pancreatic Surgery from Imperial College London and successfully cleared his MRCS from Royal College of Surgeons Edinburgh.

He has completed Ph.D (Medicine) from the prestigious University of Warwick. His thesis topic "Assessing clinical implications and immunomodulatory changes following liver resection using RF-based device in liver cancer"

Further, he has been awarded FACS from the American College of Surgeons. 


Selected Publications

Journal Articles

Machairas N, Lang H, Jayant K, et al., 2020, Intrahepatic cholangiocarcinoma: Limitations for resectability, current surgical concepts and future perspectives, European Journal of Surgical Oncology, Vol:46, ISSN:0748-7983, Pages:740-746

Huang KW, Jayant K, Lee P-H, et al., 2019, Positive immuno-modulation following radiofrequency assisted liver resection in hepatocellular carcinoma, Journal of Clinical Medicine, Vol:8, ISSN:2077-0383

Virdis F, Reccia I, Di Saverio S, et al., 2019, Clinical outcomes of primary arterial embolization in severe hepatic trauma: A systematic review, Diagnostic and Interventional Imaging, Vol:100, ISSN:2211-5684, Pages:65-75

Jayant K, Reccia I, Shapiro AMJ, 2018, Normothermic ex-vivo liver perfusion: where do we stand?, Expert Review of Gastroenterology & Hepatology, Vol:12, ISSN:1747-4124, Pages:1045-1058

Kumar J, Reccia I, Virdis F, et al., 2018, The role of normothermic perfusion In liver transplant (TRaNsIT Study): a systematic review of preliminary studies, Hpb Surgery, Vol:2018, ISSN:0894-8569, Pages:1-38

Vavra P, Roman J, Zonca P, et al., 2017, Recent Development of Augmented Reality in Surgery: A Review, Journal of Healthcare Engineering, Vol:2017, ISSN:2040-2309

Reccia I, Kumar J, Akladios C, et al., 2017, Non-alcoholic fatty liver disease: a sign of systemic disease, Metabolism-Clinical and Experimental, Vol:72, ISSN:0026-0495, Pages:94-108

Kumar J, Reccia I, Kusano T, et al., 2017, Systemic meta-analysis assessing the short term applicability of early conversion to mammalian target of rapamycin inhibitors in kidney transplant., World J Transplant, Vol:7, ISSN:2220-3230, Pages:144-151

Kumar J, Reccia Isabella, MELD scoring system: How golden is the gold., Journal of Medical Oncology and Therapeutics

More Publications